SOURCE: Equity News Circuit

Equity News Circuit

May 23, 2013 08:20 ET

Free Research Reports on BAH, INSM, KND and MNKD Issued by the Paragon Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwired - May 23, 2013) - The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Paragon is an essential resource for hundreds of thousands of investors across the country.

Booz Allen Hamilton Holding Corporation (NYSE: BAH) shares increased 8.31 percent on volume of 1.42 million shares traded to close at $18.38. The company reported revenues for the fourth quarter of fiscal 2013 were $1.55, a slight improvement from revenues of $1.54 billion in the year ago quarter.

Find out more about Booz Allen Hamilton including full access to the free equity report at: www.ParagonReport.com/BAH

Insmed Inc. (NASDAQ: INSM) shares spiked 9.8 percent on volume of 1.94 million shares traded to close at $12.44. Lazard Capital Markets' Joshua Schimmer initiated coverage on the stock with a "buy" rating and a price target of $21.00. Canaccord Genuity has also recently raised its price target on the stock to $17.00 from $12.00.

Find out more about Insmed including full access to the free equity report at: www.ParagonReport.com/INSM

Kindred Healthcare, Inc. (NYSE: KND) shares gained 9.06 percent on volume of 1.37 million shares traded to close at $13.60. Susquehanna Financial Group's Chris Rigg has recently upgraded the company's rating to "positive" from "neutral" and has also raised his price target on the stock to $17.00.

Find out more about Kindred Healthcare including full access to the free equity report at: www.ParagonReport.com/KND

MannKind Corporation (NASDAQ: MNKD) shares surged 16.23 percent on volume of 23.3 million shares traded Wednesday to close at $6.23. According to MarketWatch, an article posted on the Seeking Alpha website labeled the biotech company as ripe takeover target. Shares of MannKind have gained approximately 170.0 percent year-to-date.

Find out more about MannKind including full access to the free equity report at: www.ParagonReport.com/MNKD

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information